IOLYX

Serial Number 97258411
645

Registration Progress

Application Filed
Feb 8, 2022
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

IOLYX

Basic Information

Serial Number
97258411
Filing Date
February 8, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
645
Status Date
May 28, 2025
Application
Pending
Classes
005 042

Rights Holder

IOLYX THERAPEUTICS, INC.

03
Address
1325 Howard Ave, #904
Burlingame, CA 94010

Ownership History

Hawkeye Therapeutics, Inc.

Original Applicant
03
Menlo Park, CA

IOLYX THERAPEUTICS, INC.

New Owner Before Publication #1
03
Burlingame, CA

Legal Representation

Attorney
Susan Piascik Christoff

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

37 events
Date Code Type Description Documents
Aug 20, 2025 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Aug 20, 2025 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
May 28, 2025 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
May 28, 2025 GNFR O FINAL REFUSAL E-MAILED Loading...
May 28, 2025 CNFR R FINAL REFUSAL WRITTEN Loading...
Apr 30, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 30, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 30, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 27, 2025 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Jan 27, 2025 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Nov 7, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 7, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 7, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 13, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 13, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 13, 2024 ALIE A ASSIGNED TO LIE Loading...
Aug 19, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Aug 19, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Aug 19, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jun 28, 2024 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Jun 28, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 28, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 28, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 22, 2024 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Jun 30, 2023 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Jun 30, 2023 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Jun 30, 2023 CNSL R SUSPENSION LETTER WRITTEN Loading...
May 18, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 17, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 17, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 22, 2023 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Nov 25, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 25, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 25, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 19, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 14, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 11, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals and pharmaceutical preparations all for use in the prevention and treatment of ophthalmological, immunological, and inflammatory diseases and disorders
Class 042
Pharmaceutical research and development services; scientific and medical research services in the field of pharmaceutical development; scientific and medical information services in the field of pharmaceutical development, namely, providing information about medical and scientific research related to development of pharmaceuticals

Classification

International Classes
005 042